TABLE 9–3.
Strategies for Perimenstrual Migraine Prophylaxis
| Class | Specifics |
|---|---|
|
| |
| Nonsteroidal anti-inflammatory drugs | Naproxen 550 mg 2 times a day for 5–6 days, ideally starting 1 day before expected headache onset81 |
| Mefenamic acid up to 500 mg 3 times a day from the start of headache through menses82 | |
| The cyclooxygenase-2 (COX-2) inhibitor celecoxib has shown promise83 in pilot studies | |
| Triptans 81 | Frovatriptan 2.5 mg 2 times a day for up to 6 days, ideally beginning 1 day before expected headache onset |
| Naratriptan 1 mg 2 times a day for 5–6 days, ideally beginning 1 day before expected headache onset | |
| Zolmitriptan 2.5 mg 2 to 3 times a day for up to 7 days, ideally beginning 1 day before expected headache onset | |
| Magnesium 81 | Specific formulation studied is not available in the United States, but it is reasonable to use available forms perimenstrually; can also help with perimenstrual syndrome |
| Vitamin E | 400 IU/d for 5 days beginning 2 days before menses84 |
| Estrogen | Supplementation (“add back”) via patch or gel in teenagers who have migraine without aura83 |